Clinical trial
Randomized Trial Comparing Insulin Glargine to Ultra-Lente Insulin in Type I Diabetes
NCT00276393 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Trial Comparing Insulin Glargine to Ultra-Lente Insulin in Type I Diabetes
- Lead sponsor
- Mayo Clinic
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- July 31, 2002
- Completion date
- December 31, 2003
- Enrollment
- 22
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
type 1 diabetes